Scarica l'app Stockscreener
5.00
2.15%
0.105
Candel Therapeutics Inc Borsa (CADL) Ultime notizie
What MACD and RSI say about Candel Therapeutics Inc.July 2025 Earnings & Low Risk Entry Point Guides - Newser
How volatile is Candel Therapeutics Inc. stockWeekly Market Outlook & Smart Allocation Stock Tips - 더경남뉴스
Can Candel Therapeutics Inc. be recession proofBond Market & Weekly Consistent Profit Watchlists - خودرو بانک
What are Candel Therapeutics Inc.’s earnings expectations2025 Sector Review & Daily Stock Trend Watchlist - خودرو بانک
Can Candel Therapeutics Inc. expand its profit marginsWeekly Trend Report & Real-Time Market Sentiment Alerts - خودرو بانک
What is Candel Therapeutics Inc.’s valuation compared to sectorEarnings Recap Report & Real-Time Volume Surge Alerts - خودرو بانک
Dow Update: Is Candel Therapeutics Inc. benefiting from interest rate changesTake Profit & Verified Technical Signals - خودرو بانک
Will Candel Therapeutics Inc. benefit from macro trendsWeekly Trade Summary & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Candel Therapeutics Inc. upsideTrade Volume Summary & Precise Buy Zone Identification - Newser
Insider Purchases Worth US$3.00m See Losses As Candel Therapeutics Market Value Drops To US$280m - 富途牛牛
Advanced analytics toolkit walkthrough for Candel Therapeutics Inc.2025 Market Outlook & Weekly High Momentum Picks - Newser
Should I average down on Candel Therapeutics Inc. stockRate Cut & Free Real-Time Market Sentiment Alerts - خودرو بانک
Candel Therapeutics: Revolutionizing Solid Tumor Treatment with Viral Immunotherapies - AInvest
Candel Therapeutics: Oncolytic Immunotherapy Showing Broad Efficacy In Tough Tumors - Seeking Alpha
How to track smart money flows in Candel Therapeutics Inc.Share Buyback & Consistent Return Strategy Ideas - Newser
Chart based analysis of Candel Therapeutics Inc. trendsJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Candel Therapeutics Inc. stock daily chart insights2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
Multi asset correlation models including Candel Therapeutics Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
What’s next for Candel Therapeutics Inc. stock2025 Key Highlights & Entry Point Confirmation Signals - خودرو بانک
What momentum shifts mean for Candel Therapeutics Inc.Market Weekly Review & AI Powered Market Entry Ideas - Newser
How hedge fund analytics apply to Candel Therapeutics Inc. stockPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
How high can Candel Therapeutics Inc. stock go2025 Bull vs Bear & Stock Market Timing Techniques - Newser
Is Candel Therapeutics Inc. stock heavily shortedEarnings Risk Summary & Target Return Focused Stock Picks - خودرو بانک
Candel Therapeutics: Assessing the Impact of BofA's Downgrade on a Promising Biotech - AInvest
Candel Therapeutics Falls After Downgrade From BofA Securities - MarketScreener
Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts - Seeking Alpha
Candel Therapeutics shares fall 15.79% intraday after BofA Securities downgrades the stock. - AInvest
What does recent volatility data suggest for Candel Therapeutics Inc.Forecast Cut & AI Enhanced Trade Execution Alerts - Newser
Candel Therapeutics Downgraded to Neutral by B of A Securities - AInvest
Price action breakdown for Candel Therapeutics Inc.July 2025 Selloffs & Precise Swing Trade Alerts - Newser
BofA Securities Downgrades Candel Therapeutics to Neutral From Buy - MarketScreener
Candel Therapeutics shares rise 1.71% after-hours after appointing renowned immunotherapy expert Carl H. June to its Research Advisory Board. - AInvest
Rally Mode: Is Candel Therapeutics Inc. forming bullish engulfing patternsJuly 2025 Macro Moves & AI Powered Market Entry Strategies - خودرو بانک
Small Cap Stocks Gain Traction: MustGrow Biologics, Ocean Power Technologies, Medicus Pharma, Candel Therapeutics, Digi Power X, and G Mining Ventures Lead the Way - AInvest
Candel Therapeutics Appoints Dr. Carl H. June to Research Advisory Board to Advance Cancer Immunotherapy Development - Quiver Quantitative
Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board - The Manila Times
FDA-Approved CAR-T Pioneer Carl June Joins Candel Therapeutics to Guide Cancer Immunotherapy Development - Stock Titan
Live market analysis of Candel Therapeutics Inc.July 2025 Selloffs & Weekly Watchlist for Consistent Profits - Newser
Will Candel Therapeutics Inc. face regulatory challengesJuly 2025 Short Interest & Stepwise Trade Execution Plans - خودرو بانک
Published on: 2025-09-02 07:27:55 - beatles.ru
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):